A detailed history of Guggenheim Capital LLC transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Guggenheim Capital LLC holds 7,507 shares of DGX stock, worth $1.03 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,507
Previous 16,802 55.32%
Holding current value
$1.03 Million
Previous $2.3 Million 55.24%
% of portfolio
0.01%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$137.09 - $137.09 $1.27 Million - $1.27 Million
-9,295 Reduced 55.32%
7,507 $1.03 Million
Q2 2024

Aug 14, 2024

SELL
$125.91 - $144.34 $144,922 - $166,135
-1,151 Reduced 6.41%
16,802 $2.3 Million
Q1 2024

May 14, 2024

BUY
$123.78 - $142.11 $132,073 - $151,631
1,067 Added 6.32%
17,953 $2.39 Million
Q4 2023

Feb 14, 2024

SELL
$120.62 - $141.12 $4.68 Million - $5.48 Million
-38,836 Reduced 69.7%
16,886 $2.33 Million
Q3 2023

Nov 14, 2023

SELL
$121.86 - $144.92 $3.32 Million - $3.94 Million
-27,212 Reduced 32.81%
55,722 $6.79 Million
Q2 2023

Aug 11, 2023

SELL
$130.56 - $146.84 $352,250 - $396,174
-2,698 Reduced 3.15%
82,934 $11.7 Million
Q1 2023

May 10, 2023

SELL
$131.53 - $155.76 $986,080 - $1.17 Million
-7,497 Reduced 8.05%
85,632 $12.1 Million
Q4 2022

Feb 14, 2023

SELL
$123.31 - $157.26 $457,233 - $583,120
-3,708 Reduced 3.83%
93,129 $14.6 Million
Q3 2022

Nov 14, 2022

BUY
$121.77 - $141.1 $290,177 - $336,241
2,383 Added 2.52%
96,837 $11.9 Million
Q2 2022

Aug 15, 2022

SELL
$127.07 - $145.39 $1.94 Million - $2.22 Million
-15,295 Reduced 13.94%
94,454 $12.6 Million
Q1 2022

May 16, 2022

BUY
$129.09 - $164.35 $3.05 Million - $3.89 Million
23,661 Added 27.48%
109,749 $15 Million
Q4 2021

Feb 14, 2022

SELL
$140.36 - $173.01 $590,775 - $728,199
-4,209 Reduced 4.66%
86,088 $14.9 Million
Q3 2021

Nov 15, 2021

BUY
$132.95 - $158.0 $995,263 - $1.18 Million
7,486 Added 9.04%
90,297 $13.1 Million
Q2 2021

Aug 13, 2021

BUY
$126.66 - $141.48 $571,996 - $638,923
4,516 Added 5.77%
82,811 $10.9 Million
Q1 2021

May 13, 2021

BUY
$114.63 - $133.34 $59,263 - $68,936
517 Added 0.66%
78,295 $10 Million
Q4 2020

Feb 16, 2021

SELL
$112.7 - $128.05 $74,945 - $85,153
-665 Reduced 0.85%
77,778 $9.27 Million
Q3 2020

Nov 13, 2020

SELL
$107.05 - $130.01 $397,155 - $482,337
-3,710 Reduced 4.52%
78,443 $8.98 Million
Q2 2020

Aug 14, 2020

SELL
$73.34 - $122.61 $914,623 - $1.53 Million
-12,471 Reduced 13.18%
82,153 $9.36 Million
Q1 2020

Jun 02, 2020

SELL
$75.14 - $115.68 $1.43 Million - $2.21 Million
-19,074 Reduced 16.78%
94,624 $7.6 Million
Q4 2019

Feb 14, 2020

BUY
$100.29 - $107.99 $3.21 Million - $3.46 Million
32,029 Added 39.22%
113,698 $12.1 Million
Q3 2019

Nov 14, 2019

BUY
$97.85 - $107.42 $1.25 Million - $1.37 Million
12,771 Added 18.54%
81,669 $8.74 Million
Q2 2019

Aug 14, 2019

SELL
$85.18 - $101.94 $1.03 Million - $1.23 Million
-12,092 Reduced 14.93%
68,898 $7.01 Million
Q1 2019

May 15, 2019

SELL
$80.68 - $89.92 $3.77 Million - $4.2 Million
-46,737 Reduced 36.59%
80,990 $7.28 Million
Q4 2018

Feb 14, 2019

BUY
$79.75 - $108.38 $3.02 Million - $4.11 Million
37,906 Added 42.2%
127,727 $10.6 Million
Q3 2018

Nov 14, 2018

SELL
$105.42 - $114.99 $265,236 - $289,314
-2,516 Reduced 2.72%
89,821 $9.69 Million
Q2 2018

Aug 14, 2018

SELL
$97.35 - $113.14 $37 Million - $43.1 Million
-380,525 Reduced 80.47%
92,337 $10.2 Million
Q1 2018

May 15, 2018

SELL
$96.42 - $107.88 $3.08 Million - $3.44 Million
-31,903 Reduced 6.32%
472,862 $47.4 Million
Q4 2017

Feb 14, 2018

BUY
$90.86 - $100.24 $1.06 Million - $1.17 Million
11,654 Added 2.36%
504,765 $49.7 Million
Q3 2017

Nov 14, 2017

BUY
$91.96 - $108.35 $45.3 Million - $53.4 Million
493,111
493,111 $46.2 Million

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Guggenheim Capital LLC Portfolio

Follow Guggenheim Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.